Heart failure with reduced ejection fraction in combination with severe chronic kidney disease research hub

Swedish Cardiac And Renal Failure study-1 (SCARF-1): An open-label pilot trial to evaluate the feasibility, safety and efficacy of eplerenone in patients with heart failure with reduced ejection fraction and severe chronic kidney disease.

This study looks at a medicine called eplerenone for people with heart failure and severe kidney disease. It checks if the medicine is safe, can be used, and how well it works, especially whether people need extra treatment to manage their potassium levels.